Real-world data on the safety and efficacy of trastuzumab deruxtecan and sacituzumab govitecan in patients with advanced breast cancer: the experience of the Hellenic Cooperative Oncology Group

被引：0
|
作者：
Fountzilas, E. [1 ]
Lalla, T. [1 ]
Karakatsoulis, G. [1 ]
Papazisis, K. [1 ]
Exarchos, K. [1 ]
Koumarianou, A. [1 ]
Nikolaidi, A. [1 ]
Binas, I. [1 ]
Mauri, D. [1 ]
Karageorgopoulou, S. [1 ]
Razis, E. [1 ]
Christopoulou, A. [1 ]
Boutis, A. [1 ]
Douganiotis, G. [1 ]
Zagouri, F. [1 ]
Stamatopoulou, S. [1 ]
Spathas, N. [1 ]
Tryfonopoulos, D. [1 ]
Psyrri, A. [1 ]
Koutras, A. [1 ]
机构：
[1] Hellen Cooperat Oncol Grp HeCOG, Data Off, Athens, Greece
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 200卷
关键词：
D O I：
10.1016/j.ejca.2024.113954
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3LBA
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [41] Real-world data of efficacy and safety of denosumab on patients with breast cancer with bone metastasis: Results from Chinese clinical experience.
    Liang, Xu
    Zhang, Ruyan
    Zhu, Anjie
    Gui, Xin-Yu
    Li, Huiping
    Song, Guohong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG)
    Fountzilas, G
    Christodoulou, C
    Tsavdaridis, D
    Kalogera-Fountzila, A
    Aravantinos, G
    Razis, E
    Kalofonos, HP
    Papakostas, P
    Karina, M
    Gogas, H
    Skarlos, D
    CANCER INVESTIGATION, 2004, 22 (05) : 655 - 662
  • [43] Real World Data with Off-Label Insurance Approval of Trastuzumab Deruxtecan in Metastatic Breast Cancer
    Bobolts, Laura R.
    Mangurian, Mark
    Marur, Shanthi
    Wise, Corey
    Pozotrigo, Melissa
    Solomon, Hiywete
    Hartung, Nicole
    Ravindranathan, Meera
    Makielski, Rory
    Marur, Shika
    Toler, Andrew
    CANCER RESEARCH, 2023, 83 (05)
  • [44] Exposure-Response Analyses of Sacituzumab Govitecan Efficacy and Safety in Patients With Metastatic Triple-Negative Breast Cancer
    Sathe, Abhishek G.
    Diderichsen, Paul M.
    Fauchet, Floris
    Phan, See-Chun
    Girish, Sandhya
    Othman, Ahmed A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (02) : 570 - 578
  • [45] Efficacy and safety of disitamab vedotin after trastuzumab for HER2 positive breast cancer: a real-world data of retrospective study
    Li, Chao
    Sun, Luhao
    Liu, Zhaoyun
    Sun, Haiyin
    Wang, Xinzhao
    Yu, Qian
    Yu, Zhiyong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (02): : 869 - 879
  • [46] Efficacy and safety of disitamab vedotin after trastuzumab for HER2-positive breast cancer: A real-world data of retrospective study
    Li, C.
    Yu, Z.
    ANNALS OF ONCOLOGY, 2023, 34 : S1492 - S1492
  • [47] The efficacy of trastuzumab-deruxtecan for the treatment of patients with advanced HER2-low breast cancer
    Schlam, Ilana
    Tolaney, Sara M.
    Tarantino, Paolo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (11) : 1059 - 1066
  • [48] Real World Outcomes with Sacituzumab Govitecan in Metastatic Triple Negative Breast Cancer Patients: A Multi-Institution Study
    Alaklabi, Sabah
    Roy, Arya Mariam
    Zagami, Paola
    Held, Nicole
    Shaikh, Saba
    Chaudhary, Lubna
    Abdou, Yara
    Gandhi, Shipra
    CANCER RESEARCH, 2024, 84 (09)
  • [49] Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study
    Ozgun, M. A.
    Dogan, I.
    Eryilmaz, M. Karakurt
    Erdogan, A. P.
    Ayhan, M.
    Hafizoglu, E.
    Tolunay, P. K.
    Cavdar, E.
    Cevik, G. T.
    Demir, H.
    Dulgar, O.
    Yilmaz, B.
    Cakir, E.
    Gokyer, A.
    Unal, O. U.
    Perkin, P.
    Sakalar, T.
    Gulmez, A.
    Tasci, E. S.
    Lacin, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S892 - S892
  • [50] Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer: A Phase II Trial of the Hellenic Cooperative Oncology Group
    Gogas, Helen
    Pectasides, Dimitrios
    Kostopoulos, Ioannis
    Lianos, Evangelos
    Skarlos, Dimosthenis
    Papaxoinis, George
    Bobos, Mattheos
    Kalofonos, Haralabos P.
    Petraki, Kalliopi
    Pavlakis, Kitty
    Bafaloukos, Dimitrios
    Fountzilas, George
    CLINICAL BREAST CANCER, 2010, 10 (03) : 230 - 237
12345